News

India`s SII could resume Covishield shot production as COVID cases rise The Serum Institute of India (SII) could resume production of the Covishield COVID-19 vaccine, a company spokesperson said on Wednesday, as infections rise in the country. The world's biggest vaccine maker already has a stock of 6 million doses of Covovax, a version of a Novavax vaccine, the spokesperson added. Covishield is a version of an AstraZeneca shot.
India`s SII could resume Covishield shot production as COVID cases rise
India`s SII could resume Covishield shot production as COVID cases rise
Source: Reuters
12/04/2023 5:11:50 PM
Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in Hyderabad Serum Institute of India on Sunday announced establishment of a Dr Cyrus Poonawalla Centre of Excellence in Infectious Diseases and Pandemic Preparedness at Hyderabad. This centre will be located at Indian Institute of Public Health, Hyderabad. The Centre of Excellence (CoE) is being set up for providing the community with a centralised location for information, resources, and support during times of public health emergencies. The centre will be staffed by experienced healthcare profess...
Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in Hyderabad
Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in Hyderabad
Source: IANS
19/02/2023 3:56:24 PM
South Africa`s Aspen, India's Serum Institute sign vaccines deal for Africa Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine production lines in eastern South Africa. Aspen has a contract with Johnson & Johnson to package its COVID-19 vaccine into vials and earlier this year it extended its agreement to allow it to package, sell and distribute the vaccine under its own brand Aspenovax for Africa. But it has not received a...
South Africa`s Aspen, India's Serum Institute sign vaccines deal for Africa
South Africa`s Aspen, India's Serum Institute sign vaccines deal for Africa
Source: Reuters
31/08/2022 5:45:54 PM
Research underway to find vax against monkeypox: Adar Poonawalla  Serum Institute of India CEO Adar Poonawalla on Tuesday said that research is underway to find a vaccine against monkeypox. Poonawalla has reportedly briefed the Union Health Minister Mansukh Mandaviya on the issue in a meeting on Tuesday. Meanwhile, the total number of confirmed Monkeypox cases reached 8 on Tuesday. Mandaviya has said in the Rajya Sabha that out of total 8 cases reported in the country so far, five have the history of travelling abroad. The Health Mini...
Research underway to find vax against monkeypox: Adar Poonawalla
Research underway to find vax against monkeypox: Adar Poonawalla
Source: IANS
3/08/2022 10:01:29 AM
SII chief Cyrus S. Poonawalla gets top Johns Hopkins honour The US-based Johns Hopkins Bloomberg School of Public Health has awarded the Dean's Medal to Serum Institute of India (SII) Chairman Dr Cyrus S. Poonawalla for his outstanding work in developing and delivering affordable vaccines and contributions to the Indian biosciences industry for several decades, a statement said here on Monday. The SII, with its Covid-19 vaccines, played a huge role in fighting the Coronavirus pandemic that raged across the world in the past over two years. T...
SII chief Cyrus S. Poonawalla gets top Johns Hopkins honour
SII chief Cyrus S. Poonawalla gets top Johns Hopkins honour
Source: IANS
24/05/2022 8:57:46 AM
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI NEW DELHI  - Global vaccine-sharing network COVAX is still seeing strong demand for India-made doses of the AstraZeneca COVID-19 shot, its co-lead GAVI said, following comments from producer the Serum Institute of India (SII) that uptake had slowed sharply. The SII, the world's biggest vaccine maker, told India's CNBC-TV18 this week it would temporarily halve the vaccine's production as it had no fresh orders from the Indian government and COVAX was taking fewer doses than...
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI
Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI
Source: Reuters
9/12/2021 1:40:21 PM
Indian vaccine makers bank on boosters as demand crashes NEW DELHI  -Indian COVID-19 vaccine makers are lobbying the government to authorise boosters as supplies have so outstripped demand that one drugmaker told Reuters it had suspended a plan to produce more than 100 million doses of Russia's Sputnik shot. The Serum Institute of India (SII), the world's biggest vaccine maker, and Sputnik's Indian distributor, Dr. Reddy's Laboratories, have both said they have approached health authorities about boosters. India has said ...
Indian vaccine makers bank on boosters as demand crashes
Indian vaccine makers bank on boosters as demand crashes
Source: Reuters
8/12/2021 7:19:25 PM
India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha BENGALURU - Serum Institute of India, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement https://bit.ly/3AIBLvS on Tuesday. Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes to store vaccines including the COVID-19 vaccine Covishield. The companies did not provide any further details on the deal.
India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
Source: Reuters
17/08/2021 1:39:07 PM
India`s Serum Institute seeks approval to make Russia`s Sputnik V vaccine: local media NEW DELHI  - The Serum Institute of India has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing.
India`s Serum Institute seeks approval to make Russia`s Sputnik V vaccine: local media
India`s Serum Institute seeks approval to make Russia`s Sputnik V vaccine: local media
Source: Reuters
3/06/2021 12:41:27 PM
SII to invest 240M in UK to expand vaccine business The Serum Institute of India (SII) will invest 240 million pounds in the UK to expand its vaccine business and create multiple jobs in the country. The investment is part of the 1 billion-pound India-UK Enhanced Trade Partnership that will create nearly 6,500 jobs in Britain. The investment by the Adar Poonawalla-run SII will also see opening of a new sales office in the UK. The SII has also begun phase 1 trials in the UK of a nasal vaccine against coronavirus, in partnership with Codag...
SII to invest 240M in UK to expand vaccine business
SII to invest 240M in UK to expand vaccine business
Source: IANS
4/05/2021 11:07:53 AM
India`s Serum Institute plans to start vaccine production outside India - The Times The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times. "There's going to be an announcement in the next few days," Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday. Poonawalla said last week that the Serum Institute would be able to raise its monthly output to ...
India`s Serum Institute plans to start vaccine production outside India - The Times
India`s Serum Institute plans to start vaccine production outside India - The Times
Source: Reuters
2/05/2021 8:40:21 AM
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose NEW DELHI  - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95). "Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state ...
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
India`s Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
Source: Reuters
21/04/2021 12:51:34 PM
Centre nod for credit support for SII, Bharat Biotech In a bid to boost vaccine production amid rising Covid cases, the Centre has given in-principle approval for credit to vaccine-makers, the Serum Institute of India (SII) and Bharat Biotech, it was announced on Monday. The Finance Ministry has approved sanction of Rs 3,000 crore credit for the Serum Institute and Rs 1,500 crore to Bharat Biotech, and the credit will be disbursed at the earliest. Earlier, Adar Poonawalla, CEO of Serum Institute of India, had suggested that the company wou...
Centre nod for credit support for SII, Bharat Biotech
Centre nod for credit support for SII, Bharat Biotech
Source: IANS
20/04/2021 9:42:17 AM
India to fund capacity boost at Serum Institute as vaccines run short - Source NEW DELHI - India is set to accept the Serum Institute of India's (SII) request for a grant of 30 billion rupees ($400 million) to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters. SII, the world's biggest vaccine maker, had sought the funds to increase its monthly capacity to more than 100 million doses by the end of May, from up to 70 million currently. "We are clear that we will give whatever suppo...
India to fund capacity boost at Serum Institute as vaccines run short - Source
India to fund capacity boost at Serum Institute as vaccines run short - Source
Source: Reuters
19/04/2021 3:49:24 PM
Indian vaccine maker Serum Institute appeals to Joe Biden to lift embargo on raw material exports NEW DELHI - The Serum Institute of India (SII), the world's biggest vaccine maker, on Friday urged U.S. President Joe Biden to lift an embargo on U.S. exports of raw materials that is hurting its production of COVID-19 shots. "Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up," SII Chie...
Indian vaccine maker Serum Institute appeals to Joe Biden to lift embargo on raw material exports
Indian vaccine maker Serum Institute appeals to Joe Biden to lift embargo on raw material exports
Source: Reuters
16/04/2021 4:01:11 PM